ArticleAnnals of hematology2024

Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study.

Hui Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.